These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 6546179

  • 21. [Combined effect of interferon inducers, radiosensitizing and antineoplastic agents on solid tumors].
    Leonidze DL.
    Radiobiologiia; 1987; 27(5):696-9. PubMed ID: 3671688
    [Abstract] [Full Text] [Related]

  • 22. [Present trends in the development of radiotherapy].
    Kiseleva ES, Dar'ialova SL, Kvasov VA, Boĭko AV, Rakhmanin IuA, Poliakov PIu, Demidova LV, Zimina ES, Chernichenko AV, Ponomareva IV.
    Med Radiol (Mosk); 1991; 36(6):4-8. PubMed ID: 1861600
    [Abstract] [Full Text] [Related]

  • 23. New radiosensitizing regimens, drugs, prodrugs, and candidates.
    Vallerga AK, Zarling DA, Kinsella TJ.
    Clin Adv Hematol Oncol; 2004 Dec; 2(12):793-805. PubMed ID: 16166960
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Clinical experiences with the use of metronidazole in the radiotherapy of cancer patients].
    Cyb AF, Chmelevskaja ZI, Kudrjavceva GT.
    Radiobiol Radiother (Berl); 1985 Dec; 26(3):339-42. PubMed ID: 4059519
    [No Abstract] [Full Text] [Related]

  • 26. [Results of long-term treatment of inoperable cancer of the bladder with cisplatin and concurrent irradiation: prognostic factors of local control and survival].
    Chauvet B, Félix-Faure C, Davin JL, Choquenet C, Alfonsi M, Reboul F.
    Cancer Radiother; 1998 Apr; 2 Suppl 1():85s-91s. PubMed ID: 9749086
    [Abstract] [Full Text] [Related]

  • 27. The importance of radiobiology to cancer therapy: current practice and future perspectives.
    Hirst DG.
    Clin Oncol (R Coll Radiol); 2007 Aug; 19(6):367-9. PubMed ID: 17451922
    [No Abstract] [Full Text] [Related]

  • 28. [Perspectives in biological modulation of radiotherapy].
    Deutsch E, Huguet F.
    Bull Cancer; 2005 Jan; 92(1):90-6. PubMed ID: 16123013
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Hyperthermia: a potent enhancer of radiotherapy.
    Horsman MR, Overgaard J.
    Clin Oncol (R Coll Radiol); 2007 Aug; 19(6):418-26. PubMed ID: 17493790
    [Abstract] [Full Text] [Related]

  • 31. [Advances in radiotherapy of malignant tumors].
    Kärcher KH.
    Osterr Z Erforsch Bekampf Krebskr; 1970 Aug; 25(2):73-80. PubMed ID: 5006428
    [No Abstract] [Full Text] [Related]

  • 32. Is one Gy equal to one Gy in chemo-radiotherapy or hormono-radiotherapy?
    Corvò R, Berretta L, Andretta V.
    Rays; 2004 Aug; 29(3):287-9. PubMed ID: 15603300
    [Abstract] [Full Text] [Related]

  • 33. A phase I single-dose trial of gadolinium texaphyrin (Gd-Tex), a tumor selective radiation sensitizer detectable by magnetic resonance imaging.
    Rosenthal DI, Nurenberg P, Becerra CR, Frenkel EP, Carbone DP, Lum BL, Miller R, Engel J, Young S, Miles D, Renschler MF.
    Clin Cancer Res; 1999 Apr; 5(4):739-45. PubMed ID: 10213207
    [Abstract] [Full Text] [Related]

  • 34. Toxicity after cervical cancer treatment using radiotherapy and chemotherapy.
    Jones B.
    Clin Oncol (R Coll Radiol); 2009 Feb; 21(1):56-63. PubMed ID: 19046625
    [Abstract] [Full Text] [Related]

  • 35. International Clinical Trials in Radiation Oncology. Chemical modifiers.
    Bartelink H, Bleehen NM, Phillips TL.
    Int J Radiat Oncol Biol Phys; 1988 Feb; 14 Suppl 1():S39-49. PubMed ID: 3292481
    [No Abstract] [Full Text] [Related]

  • 36. NSCLC: primary tumor size--radiation dose-related accelerated, twice daily radiotherapy by target splitting, preceded by 2 cycles of chemotherapy--first results of a prospective study.
    Wurstbauer K, Deutschmann H, Kopp P, Kranzinger M, Merz F, Nairz O, Studnicka M, Sedlmayer F.
    Strahlenther Onkol; 2007 Dec; 183 Spec No 2():38-40. PubMed ID: 18167008
    [No Abstract] [Full Text] [Related]

  • 37. Enhancement of radiotherapy with DNA topoisomerase I-targeted drugs.
    Chen AY, Chou R, Shih SJ, Lau D, Gandara D.
    Crit Rev Oncol Hematol; 2004 May; 50(2):111-9. PubMed ID: 15157660
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.
    Timke C, Zieher H, Roth A, Hauser K, Lipson KE, Weber KJ, Debus J, Abdollahi A, Huber PE.
    Clin Cancer Res; 2008 Apr 01; 14(7):2210-9. PubMed ID: 18381963
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.